Single Nucleotide Polymorphisms in ABCC2 Associate With Tenofovir-Induced Kidney Tubular Dysfunction in Japanese Patients With HIV-1 Infection: A Pharmacogenetic Study

被引:66
作者
Nishijima, Takeshi [2 ]
Komatsu, Hirokazu [3 ]
Higasa, Koichiro [4 ]
Takano, Misao
Tsuchiya, Kiyoto
Hayashida, Tsunefusa
Oka, Shinichi [2 ]
Gatanaga, Hiroyuki [1 ,2 ]
机构
[1] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1620052, Japan
[2] Kumamoto Univ, Ctr AIDS Res, Kumamoto 860, Japan
[3] Saku Cent Hosp, Dept Community Care, Nagano, Japan
[4] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068501, Japan
关键词
DISOPROXIL FUMARATE; ANTIRETROVIRAL-NAIVE; P-GLYCOPROTEIN; RENAL SAFETY; GENE; THERAPY; ELIMINATION; ABACAVIR/LAMIVUDINE; TRANSPORTER; DISPOSITION;
D O I
10.1093/cid/cis772
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Tenofovir is a widely used antiretroviral drug although it can cause kidney tubular dysfunction (KTD). The aim of this study was to determine the association between polymorphisms in genes encoding drug transporters and KTD in Japanese patients treated with tenofovir. Methods. The association between tenofovir-induced KTD and 14 single nucleotide polymorphisms (SNPs) in the ABCC2, ABCC4, ABCC10, SCL22A6, and ABCB1 genes was investigated in 190 Japanese patients. KTD was diagnosed by the presence of at least 3 abnormalities in the following parameters: fractional tubular resorption of phosphate, fractional excretion of uric acid, urinary beta 2-microglobulin, urinary alpha 1-microglobulin, and urinary N-acetyl-beta-D-glucosaminidase. Genotyping was performed by allelic discrimination using TaqMan 5'-nuclease assays with standard protocols. Associations between genotypes and KTD were tested by univariate and multivariate logistic regression analyses. Results. KTD was diagnosed in 19 of the 190 (10%) patients. Univariate and multivariate analyses showed a significant association between KTD and genotype CC at position -24 CC (adjusted odds ratio [OR], 20.08; 95% confidence interval [CI], 1.711-235.7; P = .017) and genotype AA at position 1249 (adjusted OR, 16.21; 95% CI, 1.630-161.1; P = .017) of ABCC2. Multivariate analysis showed higher adjusted OR for patients with both homozygotes (adjusted OR, 38.44; 95% CI, 2.051-720.4; P = .015). ABCC2 haplotype -24T and 1249G was a protective haplotype for KTD (OR, 0.098; 95% CI, .002-.603; P = .003 Conclusions. This is the first study of our knowledge to identify the association between SNPs in ABCC2 and tenofovir-induced KTD in an Asian population. Close monitoring of renal function is warranted in tenofovir-treated patients with these SNPs.
引用
收藏
页码:1558 / 1567
页数:10
相关论文
共 37 条
  • [1] Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy
    Ando, Minoru
    Yanagisawa, Naoki
    Ajisawa, Atsushi
    Tsuchiya, Ken
    Nitta, Kosaku
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (10) : 3224 - 3229
  • [2] Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients - 144-week analysis
    Arribas, Jose R.
    Pozniak, Anton L.
    Gallant, Joel E.
    DeJesus, Edwin
    Gazzard, Brian
    Campo, Rafael E.
    Chen, Shan-Shan
    McColl, Damian
    Holmes, Charles B.
    Enejosa, Jeffrey
    Toole, John J.
    Cheng, Andrew K.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (01) : 74 - 78
  • [3] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [4] Systematic Review and Meta-analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV-Infected Patients
    Cooper, Ryan D.
    Wiebe, Natasha
    Smith, Nathaniel
    Keiser, Philip
    Naicker, Saraladevi
    Tonelli, Marcello
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 51 (05) : 496 - 505
  • [5] Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus
    de Vries-Sluijs, Theodora E. M. S.
    Reijnders, Jurrien G. P.
    Hansen, Bettina E.
    Zaaijer, Hans L.
    Prins, Jan M.
    Pas, Suzan D.
    Schutten, Martin
    Hoepelman, Andy I. M.
    Richter, Clemens
    Mulder, Jan W.
    de Man, Rob A.
    Janssen, Harry L. A.
    van der Ende, Marchina E.
    [J]. GASTROENTEROLOGY, 2010, 139 (06) : 1934 - 1941
  • [6] Ezinga M, 2012, 19 C RETR OPP INF 5
  • [7] Urinary β2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil furnarate
    Gatanaga, Hiroyuki
    Tachikawa, Natsuo
    Kikuchi, Yoshimi
    Teruya, Katsuji
    Genka, Ikumi
    Honda, Miwako
    Tanuma, Junko
    Yazaki, Hirohisa
    Ueda, Akihiro
    Kimura, Satoshi
    Oka, Shinichi
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (08) : 744 - 748
  • [8] Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy
    Goicoechea, Miguel
    Liu, Shanshan
    Best, Brookie
    Sun, Shelly
    Jain, Sonia
    Kemper, Carol
    Witt, Mallory
    Diamond, Catherine
    Haubrich, Richard
    Louie, Stan
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (01) : 102 - 108
  • [9] Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
    Gupta, SK
    Eustace, JA
    Winston, JA
    Boydstun, II
    Ahuja, TS
    Rodriguez, RA
    Tashima, KT
    Roland, M
    Franceschini, N
    Palella, FJ
    Lennox, JL
    Klotman, PE
    Nachman, SA
    Hall, SD
    Szczech, LA
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) : 1559 - 1585
  • [10] Urinary biomarkers in the early diagnosis of acute kidney injury
    Han, W. K.
    Waikar, S. S.
    Johnson, A.
    Betensky, R. A.
    Dent, C. L.
    Devarajan, P.
    Bonventre, J. V.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (07) : 863 - 869